Friday, January 13, 2017

Theranos cuts 155 jobs in second round of layoffs

Theranos is at it again: The embattled blood-testing startup is slashing 155 jobs, leaving just 220 to work on its tabletop diagnostic testing device. The layoffs come three months after the company dumped its questionable blood testing tech in favor of its new miniLab device.
Post a Comment